Align Technology's Chief Legal Officer Departs for Illumina
ALGN sits 43% above its 52-week low of $122.
Summary
Align Technology's Chief Legal and Regulatory Officer, Julie Coletti, resigned effective August 1, 2026, to become Chief Legal Officer at Illumina. The move follows the EU's formal antitrust investigation into Align announced on June 30.
Key Events · Executive and Board Changes · ALGN
-
Chief Legal Officer Resigns
Julie Coletti, EVP and Chief Legal and Regulatory Officer, resigned on July 6, 2026, effective August 1, to join Illumina as Chief Legal Officer.
-
Regulatory Context
The resignation follows the EU's June 30 announcement of a formal antitrust investigation into Align's Invisalign business, a matter directly overseen by the legal and regulatory function.
-
Leadership Gap
No successor has been named; the company will need to fill a critical C-suite role during an active regulatory proceeding.
Analysis · ALGN · Industrial Applications And Services
Julie Coletti, Align's top legal and regulatory executive, is leaving for a peer role at Illumina. Her departure comes just weeks after the EU opened an antitrust probe into Align's Invisalign business — a matter squarely in her purview. While the company has not cited the investigation as a factor, the timing raises questions about leadership continuity during a critical regulatory challenge. The market may view this as a modest negative given the context.
At the time of this filing, ALGN was trading at $174.48 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $12.5B. The 52-week trading range was $122.00 to $208.31. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.